Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2007
11/14/2007EP1854458A1 Use of a compound with RANKL activity
11/14/2007EP1854446A1 Antiallergic composition
11/14/2007EP1853707A2 Uses of il-23 antagonists in the treatment of diabetes mellitus
11/14/2007EP1853612A1 Purification of rapamycin
11/14/2007EP1853569A1 Ligands for g-protein coupled receptors
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853254A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/14/2007EP1664043B1 Compositions useful as inhibitors of protein kinases
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1425301B1 Therapeutic vaccine mixture for preventing and treating disorders in mammals
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1399173B1 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1117435B1 Mutant cholera holotoxin as an adjuvant
11/14/2007CN101072556A Triazoles useful as inhibitors of protein kinases
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101069743A Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
11/14/2007CN101069723A Oral liquor of anti-fatigue and intensifying immunity and preparing method
11/14/2007CN101069696A Method for preparing health-care product of oral enteric soluble foremilk immunoglobulin
11/14/2007CN101069562A Zymolysis process for preparing high-immunity regulation activity wolfberry polysaccharides using wolfberry wine residues
11/14/2007CN101069554A Method for preparing Chinese magnoliavine fruit functional salad jam
11/14/2007CN101069546A Poria-cocos eight-treasures noodles and preparing method
11/14/2007CN101069532A Blended oil in which the ratio of linoleic acid and linolenic acid is 4:1
11/14/2007CN100348725C Plasmid containing recombinant immunological toxin MIP-1ª‡-DT390 aiming at activated Th1 cell, its preparation method and uses
11/14/2007CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348268C Method for preparing carbonized resin DNA immunoadsorbent
11/14/2007CN100348266C Peptide antagonists of zonulin and methods for use of the same
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/14/2007CN100348242C Medicine for treating urticaria and skin diseas
11/14/2007CN100348212C Chinese medicine capsule used for regulating immunity, its preparation method and use
11/14/2007CN100348208C Method for preparing Chinese medicinal preparation of whiteback thundergodvine by water decoction alcohol precipitation
11/14/2007CN100348203C Hypercritical soluble propolis prescription and its preparing method
11/14/2007CN100348184C External composition containing highly unsaturated fatty acid or its salt or ester
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294477 Allergen and treatment
11/13/2007US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294345 Otorhinological delivery device
11/13/2007CA2423288C New pharmaceutical compositions containing epinastine and pseudoephedrine
11/13/2007CA2283637C Upar mimicking peptide
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2152137C Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
11/08/2007WO2007126727A2 WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
11/08/2007WO2007126439A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/08/2007WO2007126336A1 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
11/08/2007WO2007126259A1 Compositions for treating autoimmune disease containing extracts of sophora flavescens
11/08/2007WO2007126163A1 B cell-based vaccine loaded with the ligand of natural killer t cell and antigen
11/08/2007WO2007126042A1 2-aminobutanol compound and use thereof for medical purposes
11/08/2007WO2007125915A1 Solid matter containing coenzyme q
11/08/2007WO2007125823A1 Composition comprising polysaccharide having immunomodulating function as main ingredient
11/08/2007WO2007125209A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same
11/08/2007WO2007124529A1 Modulation of t helper cell-mediated immune responses
11/08/2007WO2007124526A1 Phl p 1 allergen derivative
11/08/2007WO2007105945A3 Use of non-digestable sacharides for giving an infant the best start after birth
11/08/2007WO2007055926A8 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells
11/08/2007WO2002046220A9 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/08/2007US20070259914 Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5.
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259879 Piperazine and piperidine biaryl derivatives
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259855 Thiazolyl-dihydro-indazole
11/08/2007US20070259848 N-({[1-(3,4-Dichloro-benzyl)-azetidin-3-ylmethyl]-carbamoyl}-methyl)-2-methoxy-benzamide; inflammatory or allergic condition such as an inflammatory or obstructive airways disease
11/08/2007US20070259838 17,20(Z)-Dehydro Vitamin D Analogs and Their Uses
11/08/2007US20070259826 Chimeric (Double) Decoy
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007US20070258991 Immunogenic agent therapy using plasmapheresis
11/08/2007US20070258959 CD4+CD25- T CELLS AND Tr1-LIKE REGULATORY T CELLS
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007DE10312259B4 Kosmetische oder dermopharmazeutische Zusammensetzung, umfassend ein Enzym, das in einem wässrigen Medium unlöslich ist, sowie deren Verwendung Cosmetic or dermopharmaceutical composition comprising an enzyme, which is insoluble in an aqueous medium, and the use thereof
11/08/2007CA2684314A1 Modulation of t helper cell-mediated immune responses
11/08/2007CA2649057A1 Phl p 1 allergen derivative
11/08/2007CA2647985A1 High titer recombinant influenza viruses for vaccines
11/08/2007CA2645741A1 Water soluble .beta.-glucan, glucosamine, and n-acetylglucosamine compositions and methods for making the same
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852498A1 Method of producing lactic acid bacterium having antiallergic effect
11/07/2007EP1852437A2 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
1 ... 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 ... 1172